68291-97-4 Zonisamide AKSci F988
 
 
Loading Please Wait...
  F988    
Zonisamide, 98% (HPLC)
 
1,2-Benzisoxazole-3-methanesulfonamide
Zonegran
Exceglan
more..
IDENTITY
CAS Number:68291-97-4
MDL Number:MFCD00865316
MF:C8H8N2O3S
MW:212.23
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:98% (HPLC)
Physical Form (at 20°C):Solid
Melting Point:162-168°C
Long-Term Storage:Store long-term at 2-8°C
DOT/IATA TRANSPORT INFORMATION
Not hazardous material

BIOLOGICAL INFO
Application(s):Sodium and calcium channel blocker
Form:Free Base

REVIEW
 Zonisamide is a sulfonamide anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures; infantile spasm, mixed seizure types of Lennox-Gastaut syndrome, myoclonic, and generalized tonic clonic seizure.

REFERENCES
[1]Baulac M, Brodie MJ, Patten A, Segieth J, Giorgi L (2012). Efficacy and tolerability of zonisamide versus controlled-release carbamazepine for newly diagnosed partial epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. Lancet Neurol. 11(7):579-88. PMID 22683226.
[2] McElroy SL, Winstanley E, Mori N, Martens B, McCoy J, Moeller D, Guerdjikova AI, Keck PE Jr (2012). A randomized, placebo-controlled study of zonisamide to prevent olanzapine-associated weight gain. J Clin Psychopharmacol. 32(2):165-72. PMID 22367654.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Warning

Hazard Statements
H302

Precautionary Statements
P264; P270; P301+P312; P330; P501

RELATED PRODUCTS
F988Zonisamide
X5022Zonisamide sodium salt

Current as of March 25, 2023


Download SDS Request COA

⚠️
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information.


CATEGORIES
 APIs and Bioactives > Anticonvulsants


PubChem